Prestige Consumer Healthcare Inc. reaffirmed earnings guidance for the fiscal year 2024, for the year, the company expects revenue in the range of $1,135 million to $1,140 million and Diluted EPS of $4.27 to $4.32.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.47 USD | +0.47% | +1.15% | +15.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 3.5B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PBH Stock
- News Prestige Consumer Healthcare Inc.
- Prestige Consumer Healthcare Inc. Reaffirms Earnings Guidance for the Fiscal Year 2024